Ronald Thomas Hay

12PUBLICATIONS
37CO-AUTHORS
Molecular targetsProteomics and intermolecular interactions (excl. medical proteomics)Major global burdens of diseaseCell development, proliferation and deathMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 16, 2025
PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways.

Ellis G Jaffray, Michael H Tatham, Barbara Mojsa

|Oct 11, 2024
Mechanism of degrader-targeted protein ubiquitinability.

Charlotte Crowe, Mark A Nakasone, Sarah Chandler

|Apr 22, 2024
Concerted SUMO-targeted ubiquitin ligase activities of TOPORS and RNF4 are essential for stress management and cell proliferation.

Julio C Y Liu, Leena Ackermann, Saskia Hoffmann

|Nov 02, 2023
Adenovirus E1B-55K controls SUMO-dependent degradation of antiviral cellular restriction factors.

Wing-Hang Ip, Michael H Tatham, Steewen Krohne

|Jul 20, 2023
The SUMO-NIP45 pathway processes toxic DNA catenanes to prevent mitotic failure.

Emil P T Hertz, Ignacio Alonso-de Vega, Thomas Kruse

|Mar 07, 2023
The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA.

Ellis G Jaffray, Michael H Tatham, Barbara Mojsa

Pageof 2

Frequent Collaborators

4 joint publications

Michael H Tatham

4 joint publications

Niels Mailand

3 joint publications

Julio C Y Liu

3 joint publications

Ivo A Hendriks